One month ago, NACDS RxIMPACT said it would push for congressional pharmacy tours with only 25 in-district workdays left in July and August -- and it did just that.
Momentum continues to build for bipartisan legislation that would help protect Americans’ access to pharmacist care as NACDS members urge Congressional action during the 2022 NACDS Total Store Expo in Boston.
Last week, NACDS took issue with an op-ed in The Wall Street Journal titled, “In Defense of Pharmacy Benefit Managers (PBMs),” which asserted that “swarms of drug-company lobbyists appear to have united both parties in opposition to [PBMs]” and that PBMs – unreasonably – “are taking the blame for high drug prices.”
With only 25 in-district work days left in July and August, the pharmacy community continues its great work promoting pro-patient, pro-pharmacy policy priorities to Members of Congress and their staff via the NACDS RxIMPACT Pharmacy Tour Program.
On Wednesday, Drug Store News published an opinion piece by NACDS President & CEO Steven C. Anderson.
Diverse NACDS-backed provisions would enhance patients’ access to OTC hearing aids and to biosimilar and generic medications, and would maintain flexibility in drug disposal options.
The Future of Pharmacy Care Coalition, of which NACDS serves on the Executive Committee, continues to aggressively advocate and build support for the Equitable Community Access to Pharmacist Services Act (HR 7213) — bipartisan legislation that would help ensure the continuity of accessible pharmacy-based care, during public health emergencies and every day.
NACDS RxIMPACT pharmacy tours are back in action — and reports from the field have been extremely positive.
NACDS member pharmacies and pharmacy teams are demonstrating tremendous leadership by hosting members of Congress for pharmacy tours as part of the NACDS RxIMPACT grassroots advocacy program.
NACDS insists that comprehensive DIR fee reform now depends on further legislative and regulatory action to improve predictability, fairness, and viability for pharmacies.
